Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rob Pieters

Showing results (61-70 of 392) with videos related to

Pageof 40
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Absence of global hypomethylation in promoter hypermethylated Mixed Lineage Leukaemia-rearranged infant acute lymphoblastic leukaemiaDominique J P M Stumpel, Pauline Schneider, Eddy H J van Roon, et al.
Advances in Therapy|October 11, 2023
Patient-Level Meta-analysis of Clofarabine in Acute Lymphoblastic LeukemiaSima Jeha, Hiroaki Goto, André Baruchel, et al.
Cancers|May 28, 2022
Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental StudyMargrietha van der Linde, Nikki van Leeuwen, Frank Eijkenaar, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101Jill A P Spijkers-Hagelstein, Pauline Schneider, Sandra Mimoso Pinhanços, et al.
Cancer Research|March 1, 2005
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cellsMarc Hotfilder, Silja Röttgers, Annegret Rosemann, et al.
Oncotarget|September 3, 2016
MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutationsMark Kerstjens, Emma M C Driessen, Merel Willekes, et al.
Haematologica|June 17, 2017
Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axisBob de Rooij, Roel Polak, Lieke C J van den Berk, et al.
Journal of Pediatric Hematology/Oncology|February 27, 2010
The metabolic syndrome in adult survivors of childhood cancer, a reviewMarjolein van Waas, Sebastian J Neggers, Aart-Jan van der Lelij, et al.
Cell Cycle (Georgetown, Tex.)|April 17, 2014
MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALLMarieke H van der Linden, Merel Willekes, Eddy van Roon, et al.
Leukemia & Lymphoma|September 13, 2006
High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy onlyMartine van Grotel, King H Lam, Rogier de Man, et al.
Pageof 40

Showing results (61-70 of 392) with videos related to

Sort By:
Pageof 40
European Journal of Cancer (Oxford, England : 1990)|August 28, 2012
Absence of global hypomethylation in promoter hypermethylated Mixed Lineage Leukaemia-rearranged infant acute lymphoblastic leukaemiaDominique J P M Stumpel, Pauline Schneider, Eddy H J van Roon, et al.
Advances in Therapy|October 11, 2023
Patient-Level Meta-analysis of Clofarabine in Acute Lymphoblastic LeukemiaSima Jeha, Hiroaki Goto, André Baruchel, et al.
Cancers|May 28, 2022
Effect of Treatment in a Specialized Pediatric Hemato-Oncology Setting on 5-Year Survival in Acute Lymphoblastic Leukemia: A Quasi-Experimental StudyMargrietha van der Linde, Nikki van Leeuwen, Frank Eijkenaar, et al.
European Journal of Cancer (Oxford, England : 1990)|April 8, 2014
Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101Jill A P Spijkers-Hagelstein, Pauline Schneider, Sandra Mimoso Pinhanços, et al.
Cancer Research|March 1, 2005
Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cellsMarc Hotfilder, Silja Röttgers, Annegret Rosemann, et al.
Oncotarget|September 3, 2016
MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutationsMark Kerstjens, Emma M C Driessen, Merel Willekes, et al.
Haematologica|June 17, 2017
Acute lymphoblastic leukemia cells create a leukemic niche without affecting the CXCR4/CXCL12 axisBob de Rooij, Roel Polak, Lieke C J van den Berk, et al.
Journal of Pediatric Hematology/Oncology|February 27, 2010
The metabolic syndrome in adult survivors of childhood cancer, a reviewMarjolein van Waas, Sebastian J Neggers, Aart-Jan van der Lelij, et al.
Cell Cycle (Georgetown, Tex.)|April 17, 2014
MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALLMarieke H van der Linden, Merel Willekes, Eddy van Roon, et al.
Leukemia & Lymphoma|September 13, 2006
High relapse rate in children with non-advanced nodular lymphocyte predominant Hodgkin's lymphoma (NLPHL or nodular paragranuloma) treated with chemotherapy onlyMartine van Grotel, King H Lam, Rogier de Man, et al.
Pageof 40